Novelix Pharmaceuticals Ltd (NOVE)

Currency in INR
52.50
0.00(0.00%)
Delayed Data·

NOVE Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

Technical Indicators

Strong Sell

Moving Averages

Sell

Summary:Strong Sell

Moving Averages:SellBuy: (5)Sell: (7)
Technical Indicators:Strong SellBuy: (3)Sell: (6)

Technical Indicators

Summary: Strong SellBuy: 3Neutral: 1Sell: 6
Nov 5, 2025 03:53 GMT
Name
Value
Action
RSI(14)46.906Neutral
STOCH(9,6)64.667Buy
STOCHRSI(14)0Oversold
MACD(12,26)0.16Buy
ADX(14)64.74Sell
Williams %R-75Sell
CCI(14)-108.1785Sell
ATR(14)0.86Less Volatility
Highs/Lows(14)-0.2457Sell
Ultimate Oscillator60.777Buy
ROC-1.037Sell
Bull/Bear Power(13)-1.474Sell

Moving Averages

Summary: SellBuy: 5Sell: 7
Nov 5, 2025 03:53 GMT
Name
Simple
Exponential
MA5
53.15
Sell
53.00
Sell
MA10
53.20
Sell
53.14
Sell
MA20
53.22
Sell
53.33
Sell
MA50
52.80
Sell
51.89
Buy
MA100
48.01
Buy
49.25
Buy
MA200
44.23
Buy
46.29
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic52.1652.3852.8353.0553.553.7254.17
Fibonacci52.3852.6452.7953.0553.3153.4653.72
Camarilla53.0953.1553.2153.0553.3353.3953.45
Woodie's52.2652.4352.9353.153.653.7754.27
DeMark's--52.9353.153.61--

FAQ

From a Technical Analysis Perspective, Is Novelix Pharmaceuticals a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Do the Moving Averages for NOVE Currently Stand?

The moving averages for Novelix Pharmaceuticals show a Sell outlook, considering moving averages ranging from MA5 to MA200, with 5 Buy signals and 7 Sell signals.

What Is the Current Status of the Technical Indicators for Novelix Pharmaceuticals?

The technical indicators for Novelix Pharmaceuticals are in a Strong Buy position based on daily analysis, with 11 signals on buy indicators and 0 sell signals.

What Is NOVE's 14-Day RSI?

The current Relative Strength Index (RSI) of NOVE over the 14-day period is 46.906, which suggests that the stock is a Neutral.

What Is NOVE's MACD?

NOVE's MACD is 0.160, which suggests that the stock is a Buy.

What Is NOVE's 5-Day Moving Average?

NOVE's 5-day moving average is 53.15, suggesting that the stock is a Sell.

What Is NOVE's 50-Day Moving Average?

NOVE's 50-day moving average is 52.80, suggesting that the stock is a Sell.

What Is NOVE's 200-Day Moving Average?

NOVE's 200-day moving average is 44.23, suggesting that the stock is a Buy.

What Is the Fibonacci Pivot Point Performance Value for NOVE?

The Fibonacci pivot point performance value for NOVE is 53.05.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.